|
Thursday 21st November 2019 |
Text too small? |
Pacific Edge has gone back to shareholders for another $20 million, which it said would tide it over until its cash burn ends. The bladder cancer test maker said it would raise $7 million at 15 cents per share in a placement to institutional investors and customers of local brokers, which was fu...
Read the full story at BusinessDesk
https://businessdesk.co.nz/article/pacific-edge-goes-back-to-shareholders-for-another-20m
No comments yet
RAK - 1H26: Strong first half growth and strategic momentum
Green Cross Health Interim Results to 30 September 2025
Devon Funds Morning Note - 28 November 2025
November 28th Morning Report
Pacific Edge Appoints Chief Commercial Officer
Ryman Healthcare reports 1H26 results
Tower reports record FY25 result, increased dividends
NZ King Salmon Investments Ltd releases FY25 (Sept) results
RBNZ - OCR lowered to 2.25%
SVR - Savor Interim Results and Trading Update